Group | HD | PLWH | PID |
---|---|---|---|
n | 42 | 42 | 24 |
Sex, n (%) | |||
 Men | 19 (45.3%) | 23 (54.7%) | 13 (54.2%) |
 Women | 23 (54.7%) | 19 (45.3%) | 11 (45.8%) |
Age years, n (%) | |||
 18–39 | 16 (38.1%) | 4 (9.5%) | 9 (37.5%) |
 40–59 | 12 (28.6%) | 24 (57.2%) | 10 (41.7%) |
 > 60 | 14 (33.3%) | 14 (33.3%) | 5 (20.8%) |
Immunosuppressive drugs, n (%) | |||
 Corticosteroids | 0 | 0 | 5 (19.2%) |
 Others | 0 | 0 | 5 (20.8%) |
Other characteristics, n (%) |  | CD4 count (cells/μL) 31 (73.8%) > 300 11 (26.2%) < 300 | 7 (29.2%) CVID 1 (4.1%) XLA 4 (16.7%) Monogenic diseases 8 (33.3%) ICL 4 (16.7%) Other with expected normal response |